Skip to content

Clinical trials

Observational Metabolism, Inborn Errors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Phase: Observational Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20041
20063
20071
20121
20131
20141
20151
20161
20172
20183
20195
20201
20217
20223
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting8
Unknown status7
Terminated4
Not yet recruiting2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)7
National Human Genome Research Institute (NHGRI)5
CENTOGENE GmbH Rostock3
University of Lausanne3
University Children's Hospital, Zurich2
Aga Khan University Hospital, Pakistan1
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Amicus Therapeutics1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors48
Genetic Diseases, Inborn14
Metabolic Diseases11
Rare Diseases9
Lysosomal Storage Diseases7
Brain Diseases, Metabolic, Inborn5
Amino Acid Metabolism, Inborn Errors4
Gaucher Disease4
Propionic Acidemia4
Sphingolipidoses4

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.